CONSTIPATION IN ICU

CONSTIPATION IN ICU 

1.  DEFINITION (No universal consensus)

Most ICU studies define constipation as:

  • No bowel movement for ≥3 days
  • OR need for rescue laxatives/enema
  • OR hard stools / difficult evacuation

2.  EPIDEMIOLOGY

  • Incidence: 15–83% (very common in ICU)
  • Higher in:
    • Mechanically ventilated patients
    • Sedated/paralyzed patients
    • Opioid use
    • Enteral feeding patients

3.  WHY IT MATTERS

Constipation leads to:

A. Gastrointestinal effects

  • Ileus
  • Abdominal distension
  • Increased intra-abdominal pressure (IAP)
  • Feeding intolerance aspiration risk
  • Vomiting
  • Nutritional Failure
  • Anal fissure

B. Respiratory effects

  • Diaphragmatic splinting difficult weaning
  • ventilator days

C. Systemic effects

  • Bacterial translocation sepsis risk (theoretical)
  • Delirium (gut-brain axis)

4.  PATHOPHYSIOLOGY (MULTIFACTORIAL)

A. Reduced gut motility

  • Critical illness autonomic dysfunction
  • parasympathetic tone

B. Medications (most important cause)

  • Opioids μ-receptor mediated peristalsis
  • Sedatives (propofol, benzodiazepines)
  • Anticholinergics
  • Vasopressors splanchnic perfusion

C. Electrolyte imbalance

  • Hypokalemia smooth muscle contractility
  • Hypercalcemia constipation

D. Immobility

  • Bed rest colonic motility

E. Enteral feeding issues

  • Low fiber feeds
  • Inadequate hydration

5.  RISK FACTORS 

Category

Risk Factors

Drugs

  • Opioids, sedatives,
  • anticholinergics
  • Calcium channel blockers (e.g., diltiazem, verapamil, nifedipine)
  • Antidepressants (e.g., amitriptyline)
  • Antipsychotics (e.g., quetiapine)
  • Ondansetron
  • Oral iron preparations

Electrolytes

Hypokalemia, hypercalcemia,Hypomagnesemia

ICU factors

Mechanical ventilation, sedation

Nutrition

Low fiber, inadequate fluids

Neurologic

Stroke, spinal cord injury

6.  DIAGNOSIS

A. History

  • Last bowel movement
  • Stool consistency
  • Laxative use

B. Examination

  • Abdominal distension(then Do X-ray abdomen)
  • Bowel sounds
  • Rectal exam fecal impaction

C. Monitoring tools

  • Daily bowel chart (essential in ICU)

D. Investigations (if needed)

  • X-ray abdomen fecal loading / ileus
  • CT abdomen obstruction (if suspected)

7. DIFFERENTIAL DIAGNOSIS 

Condition

Key Difference

Paralytic ileus

Absent bowel sounds, diffuse dilation

Mechanical obstruction

Colicky pain, air-fluid levels

Ogilvie syndrome (ACPO)

Massive colonic dilation (cecum >10–12 cm)

Fecal impaction

Hard stool in rectum

8.  MANAGEMENT 

  • No bowel movement is not an emergency. There is no absolute requirement for one bowel movement daily. (Normal frequency ranges from ~3/week to 3/day.)
  • Escalate therapy gradually and early rather than using multiple laxatives at once.
  • Most laxatives require 12–24 hours (or longer) to become effective.
  • Avoid rapid escalation within the first 24 hours, as this increases the risk of diarrhea, electrolyte disturbances, and fecal incontinence.
  • Reassess bowel function daily and escalate only if there is no response.

FIRST RULE: RULE OUT SURGICAL CAUSES

Before treating “constipation,” exclude:

  • Mechanical bowel obstruction
  • Paralytic ileus
  • Acute colonic pseudo-obstruction (Ogilvie)

 Clues:

  • Severe distension
  • Vomiting
  • Absent bowel sounds
  • Cecum >10–12 cm (X-ray)

CORRECT REVERSIBLE CAUSES

A. Drug review (MOST IMPORTANT)

  • Reduce/stop:
    • Opioids (if possible)
    • Anticholinergics
    • Sedatives

 If opioids required plan early PAMORA


B. Correct metabolic abnormalities

  • Hypokalemia target K⁺ >4 mEq/L
  • Hypercalcemia treat cause
  • Hypomagnesemia

C. Optimize perfusion

  • Avoid excessive vasopressors
  • Ensure adequate splanchnic perfusion

D. Hydration

  • Intubated patients: Free water flushes, ~1 liter/day.
  • Avoid dehydration (especially in enteral feeds)

NON-PHARMACOLOGICAL MANAGEMENT

A. Early enteral nutrition (VERY IMPORTANT)

  • Stimulates gut motility via:Gastrocolic reflex
  • Preferred over parenteral nutrition

B. Soluble Fiber-10-20 grams 

  • Exp- Guar gum
  • Use only if no ileus
  • Avoid in:
    • Severe sepsis
    • Gut hypoperfusion

C. Mobilization

  • Even passive limb movement helps

D. Bowel charting

  • Daily documentation:
    • Stool frequency
    • Consistency

PHARMACOLOGICAL MANAGEMENT 

 A. OSMOTIC LAXATIVES (FIRST-LINE)

Osmotic Laxative

Dose 

Polyethylene Glycol (PEG) Powder

Dose: 17–34 g/day PO or via NG tube. onset~24-48 hours

Mechanism: Non-absorbable osmotic agent that retains water in the intestinal lumen, increasing stool water content and promoting bowel movements. Advantages:Preferred osmotic laxative in many ICU patients; causes less bloating and gas than lactulose, is generally better tolerated, and has minimal electrolyte absorption.

Lactulose

Dose: 15–30 mL PO/NG two to three times daily (BD–TDS), titrated to the desired bowel movement frequency. Mechanism: Fermented by colonic bacteria into organic acids, producing an osmotic effectand acidifying the colonic lumen, which also promotes conversion of ammonia (NH₃) to ammonium (NH₄⁺). Disadvantages: Bloating, abdominal distension, flatulence, diarrhea, and potential electrolyte disturbances with excessive use.Not Preferred 

 B. STIMULANT LAXATIVES (ADD-ON)

Used if osmotic laxatives inadequate

Stimulant Laxative

Dose 

Bisacodyl

Dose: 5–10 mg PO or 10 mg rectal suppository once daily as needed. Mechanism: Directly stimulates the enteric nerves of the colon, increasing colonic peristalsis and promoting fluid secretion.contraindications-Rectal impaction,Mechanical bowel obstruction, toxic megacolon.Side effects-Abdominal cramping,Diarrhea.

Preferred over Senna

Senna (Sennosides)

Dose: 15 mg PO once daily (titrate to ~100 mg/day(Max)). Mechanism: Stimulant laxative that is converted by colonic bacteria into active metabolites, increasing colonic motility and fluid secretion.

 C. STOOL SOFTENERS

  • Docusate sodium

 Limited ICU evidence not preferred alone


D.Milk of Magnesia(magnesium hydroxide)

  • Contraindicated in renal failure (GFR <20-30 ml/min)

E. RECTAL THERAPY (ESCALATION)

Manual disimpaction

  • For fecal impaction
  • Requires lubrication + analgesia

Enemas

Enemas are generally not preferred.

Indications:

  • Suspected distal stool retention and you want to avoid digital disimpaction.
  • Spinal cord injury causing a lack of rectal sensation

Contraindications to Enemas

  • Inability to retain or expel the enema (e.g., severe altered mental status, significant neurologic dysfunction, absent rectal control).
  • Sodium phosphate enemas: Avoid in CKD/AKI or significant renal dysfunction due to the risk of severe hyperphosphatemia, hypocalcemia, and acute phosphate nephropathy.
  • Suspected colonic perforation or high perforation risk, e.g., toxic megacolon, fulminant colitis, or severe acute colonic inflammation.

⚠️ Also avoid/use extreme caution in suspected bowel obstruction, recent colorectal surgery, severe neutropenia/thrombocytopenia (risk of mucosal injury), or severe anorectal disease (e.g., painful fissure, severe hemorrhoids).

Other Options:

  1. Glycerin suppository
  2. Bisacodyl suppository

PROKINETIC AGENTS (IF ILEUS COMPONENT)

1. Metoclopramide

  • Dose:10 mg IV TDS
  • Action:Dopamine antagonist gastric emptying

2. Erythromycin

  • Dose:200 mg IV BD
  • Mechanism:Motilin receptor agonist

 Useful in:

  • Feed intolerance
  • Gastroparesis

OPIOID-INDUCED CONSTIPATION 

Pathophysiology:

  • μ-receptor activation peristalsis + absorption

Treatment: PAMORAs (Peripheral μ-opioid receptor antagonists)

Do NOT reverse analgesia add non-opioid analgesic (e.g., pain-dose ketamine).

1. Enteral naloxone

  • Dose:4-8 mg enteral naloxone via feeding tube, every six hours if needed

2. Methylnaltrexone was ineffective in the MOTION trial.


REFERENCES

  1. Irwin and Rippe’s Intensive Care Medicine
  2. Sayuk GS, Yu QT, Shy C. Management of Constipation in Hospitalized Patients. J Clin Med. 2023 Sep 23;12(19):6148. doi: 10.3390/jcm12196148. PMID: 37834791; PMCID: PMC10573544.
Scroll to Top